Kalorama Information’s In Vitro Diagnostic (IVD) Trends and Market Update, 2025 provides the latest insights into the dynamic IVD market amid ongoing economic and global uncertainties. Published twice a year—first in April 2025 and again in Q4 2025, following the release of Kalorama’s annual 1,600-page study, The Worldwide Market for In Vitro Diagnostics (IVD), 18th Edition—this report serves both as a standalone resource and a companion to Kalorama’s annual flagship IVD analysis.
In 2024, the IVD market continued to expand, with most segments experiencing growth, despite the decline in COVID-19 testing revenues. AI-driven innovations, regulatory shifts, and changes in global healthcare spending are shaping the competitive landscape, reinforcing the resilience of the IVD sector.
Key growth areas attracting industry attention and that are anticipated to play a significant role in the future of IVD include:
- Point-of-care diabetes testing
- Companion diagnostics technologies
- Immunochemistry
- Mass spectrometry
- Nucleic acid assays
- HPV molecular diagnostics
- New product developments shaping IVD innovation
- Competitive landscape insights and activities of key players
- Emerging opportunities and strategic growth areas
- Worldwide IVD Market Update - April 2025
- IVD Market Demand and Growth
- Table Segment Performance Commentary, Q1-Q4 2024
- Table Global In Vitro Diagnostic Sales, by Product Market, 2024 ($ million) [Blood bank molecular - NAT Screens, Blood grouping/typing, Circulating tumor cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, molecular, D-dimer, Hematology - Core Lab, Histology/cytology, HPV, molecular, Immunoassays - non-isotopic (Immuno - Infectious disease, Other immune, Immuno - Blood bank screening, Drugs of Abuse, Diabetes HbA1c, lab), Mass Spectrometry, Microbiology (ID/AST), Microbiology (molecular), Microbiology - Mass Spectrometry, Nucleic acid assays/genetic tests, Other (transplant testing, other, etc.), POC, OTC diabetes, POC, OTC other, POC, professional/hospital]
- Table Quarterly IVD Segment Performance, by Segment, Q1 2024 - Q4 2024 ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other]
- Table IVD Segment Performance, Total Market Value, 2024 ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other]
- COVID-19 Diagnostic Markets
- Table COVID-19 Product Sales, 2024 ($ million) [Immunoassay (Antigen, Serology), Molecular, Rapid]
- Effect of COVID-19 on Market Segments
- Table IVD Market Excluding and with COVID-19, 2024 ($ million)
- Table IVD Market Distribution, by Segment, 2024 (%) [IVD Market Excluding COVID-19 Assays and Instruments, COVID-19 Assays and Instruments]
- Table IVD Market by COVID-19 and non-COVID Markets, Quarterly Performance, 2024 ($ million) [IVD Market Excluding COVID-19 Assays and Instruments, COVID-19 Assays and Instruments]
- Table Global In Vitro Diagnostic Market, YoY Growth 2023-2024 (%) [Blood bank molecular - NAT Screens, Blood grouping/typing, Circulating tumor cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, molecular, D-dimer, Hematology - Core Lab, Histology/cytology, HPV, molecular, Immunoassays - non-isotopic (Immuno - Infectious disease, Other immune, Immuno - Blood bank screening, Drugs of Abuse, Diabetes HbA1c, lab), Mass Spectrometry, Microbiology (ID/AST), Microbiology (molecular), Microbiology - Mass Spectrometry, Nucleic acid assays/genetic tests, Other (transplant testing, other, etc.), POC, OTC diabetes, POC, OTC other, POC, professional/hospital]
- Table Global In Vitro Diagnostic Market - YoY Growth 2023-2024 (%) [Blood bank molecular - NAT Screens, Blood grouping/typing, Circulating tumor cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, molecular, D-dimer, Hematology - Core Lab, Histology/cytology, HPV, molecular, Immunoassays - non-isotopic (Immuno - Infectious disease, Other immune, Immuno - Blood bank screening, Drugs of Abuse, Diabetes HbA1c, lab), Mass Spectrometry, Microbiology (ID/AST), Microbiology (molecular), Microbiology - Mass Spectrometry, Nucleic acid assays/genetic tests, Other (transplant testing, other, etc.), POC, OTC diabetes, POC, OTC other, POC, professional/hospital]
- IVD Market Demand and Growth
- Product Trends and New Developments
- Selected New - Q4 2024 and Q1 2025: Core IVD Product Launches, Developments, and Trends
- Liquid Biopsy
- Selected New - Q4 2024 and Q1 2025: Core IVD Product Launches, Developments, and Trends
- Top IVD Market Participant Results
- Selected Competitive Leader Updates
- Table IVD Segment Growth by Leading Competitors, Change in Sales 2023-2024 (%) [Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Dexcom, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific]
- Table IVD Sales Changes in Market Distribution, 2021-2024 - Roche and Abbott Battle for #1 Spot (%) [Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Dexcom, Exact Sciences, Hologic, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Werfen, Others]
- Table Comparison of Total Diagnostic Sales for Abbott vs Roche, 2022-2024 ($ million)
- Q4 2024, Q1 2025 M&A Activity
- Table Q4 2024, Q1 2025 Merger and Acquisition Activity
- Abbott Laboratories
- Table Abbott Corporate Summary
- Becton Dickinson and Co
- Table Becton Dickinson Corporate Summary
- bioMérieux SA
- Table bioMérieux Corporate Summary
- Danaher Corporation
- Table Danaher Corporation Summary
- Dexcom, Inc
- Table Dexcom Corporate Summary
- Exact Sciences
- Table Exact Sciences Corporate Summary
- QuidelOrtho Corporation
- Table QuidelOrtho Corporate Summary
- Roche Diagnostic
- Table Roche Diagnostic Corporate Summary
- Siemens Healthineers
- Table Siemens Healthineers Corporate Summary
- Sysmex Corporation
- Table Sysmex Corporate Summary
- Thermo Fisher Scientific
- Table Thermo Fisher Scientific Corporate Summary
- Selected Competitive Leader Updates
- New Opportunities
- Staffing Shortages
- LDT Update
- IVDR Compliance Deadline Approaches
- Table IVDR New Risk-based Classification System
- Telemedicine
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook